where: Rv - (C1 - C4)-alkyl; R6 - H or OH; Z - the group (CH2)n where: when n = 0 then T - group of the formula (IV) where p = 2-3, R - (C1 - C3)-alkyl; when n = 1 then T - group of the formula (V) where p' and p'' = 3-4; when n = 2 then T - group of the formula (VI) where p = 2-3, or their acid-additive pharmaceutically acceptable salts. Intermediate compounds of the formula where: R - (C1 - C3)-alkoxy-group; Rv and Z - as indicated above, and pharmaceutical composition based on compounds of the formula (I). Compounds of the formula (I) were synthesized by interaction of amine of the formula (II) with compound of the formula (III) . When compound of the formula (I) is synthesized where R6 - OH then intermediate compound of the formula (I) reacts with hydrogen halide acid. Synthesized compounds were used in pharmacy. EFFECT: improved method of synthesis. 7 cl, 3 tbl"/> 3-AMINOPYRIDAZINE DERIVATIVES OR THEIR ACID-ADDITIVE PHARMACEUTICALLY ACCEPTABLE SALTS, INTERMEDIATE COMPOUNDS, METHOD OF SYNTHESIS OF 3-AMINOPYRIDAZINE DERIVATIVES OR THEIR ACID-ADDITIVE PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION
首页> 外国专利> 3-AMINOPYRIDAZINE DERIVATIVES OR THEIR ACID-ADDITIVE PHARMACEUTICALLY ACCEPTABLE SALTS, INTERMEDIATE COMPOUNDS, METHOD OF SYNTHESIS OF 3-AMINOPYRIDAZINE DERIVATIVES OR THEIR ACID-ADDITIVE PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION

3-AMINOPYRIDAZINE DERIVATIVES OR THEIR ACID-ADDITIVE PHARMACEUTICALLY ACCEPTABLE SALTS, INTERMEDIATE COMPOUNDS, METHOD OF SYNTHESIS OF 3-AMINOPYRIDAZINE DERIVATIVES OR THEIR ACID-ADDITIVE PHARMACEUTICALLY ACCEPTABLE SALTS, PHARMACEUTICAL COMPOSITION

机译:3-氨基哒嗪衍生物或其酸可吸收的药用盐,中间体化合物,3-氨基吡啶嗪衍生物或其酸可药用的药用盐,药物组合物的合成方法

摘要

FIELD: organic chemistry. SUBSTANCE: product: 3-aminopyridazine derivatives of the formula (I) where: Rv - (C1 - C4)-alkyl; R6 - H or OH; Z - the group (CH2)n where: when n = 0 then T - group of the formula (IV) where p = 2-3, R - (C1 - C3)-alkyl; when n = 1 then T - group of the formula (V) where p' and p'' = 3-4; when n = 2 then T - group of the formula (VI) where p = 2-3, or their acid-additive pharmaceutically acceptable salts. Intermediate compounds of the formula where: R - (C1 - C3)-alkoxy-group; Rv and Z - as indicated above, and pharmaceutical composition based on compounds of the formula (I). Compounds of the formula (I) were synthesized by interaction of amine of the formula (II) with compound of the formula (III) . When compound of the formula (I) is synthesized where R6 - OH then intermediate compound of the formula (I) reacts with hydrogen halide acid. Synthesized compounds were used in pharmacy. EFFECT: improved method of synthesis. 7 cl, 3 tbl
机译:领域:有机化学。物质:产品:式(I)的3-氨基哒嗪衍生物其中:R v -(C 1 -C 4 )-烷基; R 6 -H或OH; Z-组(CH 2 n 其中:当n = 0时,T-公式(IV)的组其中p = 2-3,R-(C 1 -C 3 ) -烷基;当n = 1时,则T-公式(V)的组其中p'和p ''= 3-4;当n = 2时,则T-公式(VI)的组其中p = 2- 3,或其酸加成的药学上可接受的盐。公式为<图像文件=“ 00000006.GIF” he =“ 22” imgContent =“ undefined” imgFormat =“ GIF” wi =“ 41” />的中间化合物其中:R -(C 1 -C 3 )-烷氧基;如上所述的R v 和Z-以及基于式(I)化合物的药物组合物。通过式(II)的胺的相互作用合成式(I)的化合物。<图像文件=“ 00000007.GIF” he =“ 14” imgContent =“ undefined” imgFormat =“ GIF” wi =“ 14” />加上式(III)的化合物。当合成其中R 6- -OH的式(I)化合物时,式(I)的中间体化合物与卤化氢酸反应。合成的化合物用于药学。效果:改进的合成方法。 7厘升,3汤匙

著录项

  • 公开/公告号RU2088577C1

    专利类型

  • 公开/公告日1997-08-27

    原文格式PDF

  • 申请/专利权人 ELF SANOFI (FR);

    申请/专利号SU19925011796

  • 申请日1992-05-15

  • 分类号C07D237/20;C07D451/02;C07D451/04;C07D487/04;A61K31/50;

  • 国家 RU

  • 入库时间 2022-08-22 03:15:45

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号